This notice is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and Solicitation for Commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation document will not be issued. Submit offers on RFQ-RML-C-1771561.

This solicitation is a request for quotes (RFQ).The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2005-87, effective 03/16/2016.
The associated North American Industry Classification System (NAICS) code for this procurement is 325413 with a small business size standard of 1250 employees.
This is not a total small business set aside.

The National Institute of Allergy and Infectious Diseases (NIAID), Rocky Mountain Laboratories, is seeking to purchase Life Technologies brand media, chemicals, and biologicals. This is a brand name request for quotes.

All interested companies shall provide quotation(s) for the following:
1 10% Tris glycine gel 1.0mm 10well, 10/box EC6075BOX 6 each
2 10% Tris glycine 1.0mm 15well, 10/box EC60755BOX 6 each
3 Novex midi 10% TG 1.0mm 20well, 10/box WT0102BOX 6 each
4 NuPAGE 10% BT 1.0mm 15well 10/box NP0303BOX 4 each
5 NuPAGE 4-12% BT 1.5mm 15well, 10/box NP0336BOX 4 each
6 Lipofectamine 2000, 0.3ml 11668030 4 each
7 1kb plus DNA ladder, 250ug 10787-018 3 each
8 100bp DNA ladder, 50ug 15628-019 3 each
9 Spectra multicolor broad range protein ladder, 2x 250ul 26634 2 each
10 PCR2.1 Vector cloning kit, 20 reactions K2020-20 2 each
11 Taq DNA polymerase, 500U 10342-020 2 each
12 Superscript Vilo cDNA synthesis kit, 50 reactions 11754-050 3 each
13 Superscript III Rev transcript, 10,000 units 18080-044 2 each
14 Lipofectamine RNAiMAX, 0.75ml 13778-075 3 each
15 iBlot NC gel transfer stacks regular, 10/box IB23001 6 each
16 iBlot transfer PVDF regular, 10/box IB401001 4 each
17 Lipofectamine LTX, 1ml 15338-100 3 each
18 Accuprime Taq DNA pol, 200 reactions 12339-016 2 each
19 Taqman fast advanced master mix, 5ml 4444557 2 each
20 Gibco DMEM, high glucose, glutamax, HEPES, 10x 500ml 10564-029 6 each
21 Gibco DMEM, 10x 500ml 11995-073 6 each
22 OPTIMEM, 10x 500ml 31985-088 6 each
23 Penicillin streptomycin, 100ml 15070-063 15 each
24 Trypsin 0.25% EDTA, 20x 100ml 25200-114 2 each

Submission Deadline and Point of Contact: Submission shall be received not later than April 8th, 2016 1:00 p.m. MST. Offers may be e-mailed to Peggy Schott at [email protected].

Place of Performance:
Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, MT 59840, United States

Award will be based on the capability of the item offered to meet the above stated salient characteristics, price, past performance, delivery, warranty, and the best value to the government.

PROVISIONS AND CLAUSES
The government intends to award a firm, fixed price purchase order as a result of this solicitation that will included the terms and conditions set forth herein.

The following additional FAR & HHSAR provisions and clauses are incorporated by reference and applicable to this requirement:

The following FAR provisions apply to this acquisition:
FAR 52.212-1 Instructions to Offerors Commercial Items (Oct 2015)
FAR 52.212-2 Evaluation -- Commercial Items (Oct 2014)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Mar 2016)
Offerors must complete annual representations and certifications on-line at http://www.sam.gov in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items
FAR 52.203-98 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (DEVIATION 2015-02)
FAR 52.203-99 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (DEVIATION 2015-02)
The following contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (May 2015)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (March 2016)
FAR 52.204-16 Commercial and Government Entity Code Reporting (July 2015)
FAR 52.204-18 Commercial and Government Entity Code Maintenance (July 2015)

*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html or, upon request, either by telephone or fax.

This is a brand name, open-market combined synopsis/solicitation for Life Technologies media, chemicals, and biologicals as defined herein. The government intends to award a fixed-price purchase order as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein.

Submission shall be received not later than April 8th, 2016 by 1:00 p.m. MST.

Offers may be mailed, e-mailed or faxed to Peggy Schott at [email protected] or Fax to 406-363-9288. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)

All responsible sources may submit an offer that will be considered by this Agency.
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Peggy Schott at [email protected].